400 related articles for article (PubMed ID: 30328062)
1. The Safety of Fecal Microbiota Transplantation for Crohn's Disease: Findings from A Long-Term Study.
Wang H; Cui B; Li Q; Ding X; Li P; Zhang T; Yang X; Ji G; Zhang F
Adv Ther; 2018 Nov; 35(11):1935-1944. PubMed ID: 30328062
[TBL] [Abstract][Full Text] [Related]
2. Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn's disease.
Li P; Zhang T; Xiao Y; Tian L; Cui B; Ji G; Liu YY; Zhang F
Appl Microbiol Biotechnol; 2019 Jan; 103(1):349-360. PubMed ID: 30357440
[TBL] [Abstract][Full Text] [Related]
3. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results.
Cui B; Feng Q; Wang H; Wang M; Peng Z; Li P; Huang G; Liu Z; Wu P; Fan Z; Ji G; Wang X; Wu K; Fan D; Zhang F
J Gastroenterol Hepatol; 2015 Jan; 30(1):51-8. PubMed ID: 25168749
[TBL] [Abstract][Full Text] [Related]
4. Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn's Disease.
Yang Z; Bu C; Yuan W; Shen Z; Quan Y; Wu S; Zhu C; Wang X
Dig Dis Sci; 2020 Jan; 65(1):150-157. PubMed ID: 31367877
[TBL] [Abstract][Full Text] [Related]
5. Fecal Microbiota Transplantation is a Promising Switch Therapy for Patients with Prior Failure of Infliximab in Crohn's Disease.
Li Q; Ding X; Liu Y; Marcella C; Dai M; Zhang T; Bai J; Xiang L; Wen Q; Cui B; Zhang F
Front Pharmacol; 2021; 12():658087. PubMed ID: 34079458
[No Abstract] [Full Text] [Related]
6. Efficacy of faecal microbiota transplantation in Crohn's disease: a new target treatment?
Xiang L; Ding X; Li Q; Wu X; Dai M; Long C; He Z; Cui B; Zhang F
Microb Biotechnol; 2020 May; 13(3):760-769. PubMed ID: 31958884
[TBL] [Abstract][Full Text] [Related]
7. [Effect of intestinal preparation on the efficacy and safety of fecal microbiota transplantation treatment].
Chen QY; Tian HL; Yang B; Lin ZL; Zhao D; Ye C; Zhang XY; Qin HL; Li N
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(Z1):48-55. PubMed ID: 32594726
[No Abstract] [Full Text] [Related]
8. Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study.
Sokol H; Landman C; Seksik P; Berard L; Montil M; Nion-Larmurier I; Bourrier A; Le Gall G; Lalande V; De Rougemont A; Kirchgesner J; Daguenel A; Cachanado M; Rousseau A; Drouet É; Rosenzwajg M; Hagege H; Dray X; Klatzman D; Marteau P; ; Beaugerie L; Simon T
Microbiome; 2020 Feb; 8(1):12. PubMed ID: 32014035
[TBL] [Abstract][Full Text] [Related]
9. Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile.
Gutin L; Piceno Y; Fadrosh D; Lynch K; Zydek M; Kassam Z; LaMere B; Terdiman J; Ma A; Somsouk M; Lynch S; El-Nachef N
United European Gastroenterol J; 2019 Jul; 7(6):807-814. PubMed ID: 31316785
[TBL] [Abstract][Full Text] [Related]
10. A Two-Week Fecal Microbiota Transplantation Course in Pediatric Patients with Inflammatory Bowel Disease.
Karolewska-Bochenek K; Grzesiowski P; Banaszkiewicz A; Gawronska A; Kotowska M; Dziekiewicz M; Albrecht P; Radzikowski A; Lazowska-Przeorek I
Adv Exp Med Biol; 2018; 1047():81-87. PubMed ID: 29151253
[TBL] [Abstract][Full Text] [Related]
11. Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
Kong L; Lloyd-Price J; Vatanen T; Seksik P; Beaugerie L; Simon T; Vlamakis H; Sokol H; Xavier RJ
Gastroenterology; 2020 Dec; 159(6):2193-2202.e5. PubMed ID: 32860788
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation for induction of remission in Crohn's disease: a systematic review and meta-analysis.
Zhou S; Cui Y; Zhang Y; Zhao T; Cong J
Int J Colorectal Dis; 2023 Mar; 38(1):62. PubMed ID: 36882658
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation for Crohn's disease: a systematic review and meta-analysis.
Cheng F; Huang Z; Wei W; Li Z
Tech Coloproctol; 2021 May; 25(5):495-504. PubMed ID: 33759066
[TBL] [Abstract][Full Text] [Related]
14. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.
Suskind DL; Brittnacher MJ; Wahbeh G; Shaffer ML; Hayden HS; Qin X; Singh N; Damman CJ; Hager KR; Nielson H; Miller SI
Inflamm Bowel Dis; 2015 Mar; 21(3):556-63. PubMed ID: 25647155
[TBL] [Abstract][Full Text] [Related]
15. Fecal microbiota transplantation therapy in Crohn's disease: Systematic review.
Fehily SR; Basnayake C; Wright EK; Kamm MA
J Gastroenterol Hepatol; 2021 Oct; 36(10):2672-2686. PubMed ID: 34169565
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy analysis of fecal microbiota transplantation in the treatment of 406 cases with gastrointestinal disorders].
Li N; Tian H; Ma C; Ding C; Ge X; Gu L; Zhang X; Yang B; Hua Y; Zhu Y; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):40-46. PubMed ID: 28105618
[TBL] [Abstract][Full Text] [Related]
17. Rescue fecal microbiota transplantation for antibiotic-associated diarrhea in critically ill patients.
Dai M; Liu Y; Chen W; Buch H; Shan Y; Chang L; Bai Y; Shen C; Zhang X; Huo Y; Huang D; Yang Z; Hu Z; He X; Pan J; Hu L; Pan X; Wu X; Deng B; Li Z; Cui B; Zhang F
Crit Care; 2019 Oct; 23(1):324. PubMed ID: 31639033
[TBL] [Abstract][Full Text] [Related]
18. [Effect of fecal bacterial preservation time on the outcomes of fecal microbiota transplantation for slow transit constipation].
Lin ZL; Chen QY; Tian HL; Yang B; Zhao D; Ye C; Zhang XY; Ma CL; Qin HL; Li N
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(Z1):56-62. PubMed ID: 32594727
[No Abstract] [Full Text] [Related]
19. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals.
Agrawal M; Aroniadis OC; Brandt LJ; Kelly C; Freeman S; Surawicz C; Broussard E; Stollman N; Giovanelli A; Smith B; Yen E; Trivedi A; Hubble L; Kao D; Borody T; Finlayson S; Ray A; Smith R
J Clin Gastroenterol; 2016; 50(5):403-7. PubMed ID: 26352106
[TBL] [Abstract][Full Text] [Related]
20. Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.
Allegretti JR; Kassam Z; Carrellas M; Mullish BH; Marchesi JR; Pechlivanis A; Smith M; Gerardin Y; Timberlake S; Pratt DS; Korzenik JR
Am J Gastroenterol; 2019 Jul; 114(7):1071-1079. PubMed ID: 30730351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
